ホーム>>Lipids>> Glycerophospholipids>>PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt)

PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt) (Synonyms: DPPI3,4,5P3, Phosphatidylinositol3,4,5triphosphate C16)

カタログ番号GC44750

リン酸イノシトール脂質は、全体の細胞膜リン脂質のわずかな割合を占めています。

Products are for research use only. Not for human use. We do not sell to patients.

PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt) 化学構造

Cas No.: 1628353-02-5

サイズ 価格 在庫数 個数
100μg
$64.00
在庫あり
500μg
$286.00
在庫あり
1mg
$508.00
在庫あり
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The phosphatidylinositol phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(3,4,5)-P3 can serve as an anchor for the binding of signal transduction proteins bearing pleckstrin homology (PH) domains. Centuarin α and the Akt-family of GTPase activating proteins are examples of PtdIns-(3,4,5)-P3-binding proteins. Protein-binding to PtdIns-(3,4,5)-P3 is important for cytoskeletal rearrangements and membrane trafficking. PtdIns-(3,4,5)-P3 is resistant to cleavage by PI-specific phospholipase C (PLC). Thus, it is likely to function in signal transduction as a modulator in its own right, rather than as a source of inositol tetraphosphates. For further reading on inositol phospholipids, see also references and .

レビュー

Review for PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PtdIns-(3,4,5)-P3 (1,2-dipalmitoyl) (sodium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.